Navigation Links
Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection
Date:8/28/2008

VIENNA, Austria, Aug. 28 /PRNewswire/ -- Intercell AG (VSE: ICLL) today announced that its collaborator Merck & Co., Inc. has initiated a Phase II clinical trial of V710, an investigational vaccine for the prevention of Staphylococcus aureus (S. aureus) infections. This randomized double blind, placebo controlled study aims to evaluate the safety and immunogenicity of the vaccine candidate in patients with end-stage kidney disease on hemodialysis. This trial start follows the initiation of a separate Phase II trial in December 2007.

Gerd Zettlmeissl, CEO of Intercell, commented "We are very pleased that our strategic partner Merck has chosen to initiate a further Phase II clinical trial. We look forward to continued progress of the program building on clinical data obtained so far."

The S. aureus vaccine candidate is based on a conserved protein antigen discovered by Intercell and licensed to Merck & Co., Inc. in 2004 on an exclusive worldwide basis. Merck is responsible for clinical development, manufacturing and marketing. Intercell is eligible to receive milestone payments and royalties on future net sales. In Phase I clinical trials the S. aureus candidate vaccine was shown to be immunogenic and generally well tolerated.

Hospital-acquired Infections

Hospital-acquired infections caused by bacteria are one of the major causes of death and serious illness. Intercell has embarked on a large scale, comprehensive and multi-target antigen identification program to contribute to vaccine efforts in this field. Besides Merck's S. aureus vaccine, based on an antigen identified by Intercell, Intercell is developing a vaccine against hospital-acquired infections caused by Pseudomonas aeruginosa (Phase II/III trial is expected to be initiated in 2008) and a Pneumococcus vaccine (Phase I trials planned for end 2008). Furthermore Intercell has ongoing pre-clinical programs for Enterococcus and Klebsiella vaccine discovery.

About S. aure
'/>"/>

SOURCE Intercell AG
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)..., Dec. 3 Omnicell, Inc ...on system solutions to acute healthcare facilities...m (CHS), the largest healthcare system in the Car...in the nation, has chosen Omnicell OmniRx® au...treamline management of medications in its hospita...
(Date:12/3/2009)... 3 Milestone Scientific ...ader in advanced injection technologies, today ann...th China National Medicines Corporation Ltd. (d/b/...l Co. Ltd., both incorporated in the People,s Repu...nd epidural drug delivery instruments. Under an "a...
(Date:12/3/2009)...ewswire/ -- MicroCHIPS, a developer of intelligent...as been named a 2010 Technology Pioneer by the Wor...d for pioneering a novel medical device platform t... bridge the gap between disease monitoring and tre...cability, from ,rescue, applications in diabetes a...
Breaking Medicine Technology:Omnicell Selected by Nation's Third Largest Public Healthcare System for Medication Management Systems 2Omnicell Selected by Nation's Third Largest Public Healthcare System for Medication Management Systems 3Omnicell Selected by Nation's Third Largest Public Healthcare System for Medication Management Systems 4Milestone Scientific to Establish Joint Venture to Develop Medical Drug Delivery Instruments 2Milestone Scientific to Establish Joint Venture to Develop Medical Drug Delivery Instruments 3MicroCHIPS Named 2010 Technology Pioneer by World Economic Forum 2CombinatoRx and Neuromed Sign Merger Agreement 50637 1CombinatoRx and Neuromed Sign Merger Agreement 50637 2CombinatoRx and Neuromed Sign Merger Agreement 50637 3CombinatoRx and Neuromed Sign Merger Agreement 50637 4CombinatoRx and Neuromed Sign Merger Agreement 50637 5CombinatoRx and Neuromed Sign Merger Agreement 50637 6CombinatoRx and Neuromed Sign Merger Agreement 50637 7CombinatoRx and Neuromed Sign Merger Agreement 50637 8CombinatoRx and Neuromed Sign Merger Agreement 50637 9Successful Beginning for Wellstone Muscular Dystrophy Center at Boston Biomedical Research Institute 50632 1Successful Beginning for Wellstone Muscular Dystrophy Center at Boston Biomedical Research Institute 50632 2Monthly Pet Pill Could Kill Fleas Ticks 50628 1Monthly Pet Pill Could Kill Fleas Ticks 50628 2
...W ORLEANS, La.--(BUSINESS WIRE)--Mar 26, 2007 - A ...itrate (ISDN) and hydralazine,(HYD) used in V-HeFT... dose combination, used in the African American He...valence. Non-bioequivalence,in the formulations us...ery different results in decreasing mortality. Usi...
...W ORLEANS--(BUSINESS WIRE)--Mar 26, 2007 - Study r...hospholipase A2 (Lp-PLA2), a,cardiovascular-specif...aque that can lead to heart attack and stroke, is,...ients with the,metabolic syndrome--a serious medic...ans. The results, which were presented yesterday,a...
Other Medicine Technology:Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 2Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 3Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 4Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 5Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2,Predicts Heart Disease Risk in Metabolic Syndrome Patients 2Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2,Predicts Heart Disease Risk in Metabolic Syndrome Patients 3
(Date:12/3/2009)... , WASHINGTON, Dec. 3 /PRNewswire-USNewswi...d.) amendment to the Senate health care bill by a ...require abortion coverage, but it also fails to ex...ervices Administration (HRSA) could categorize abo...commend coverage for abortion by all private plans...
(Date:12/3/2009)... , SILVER SPRING, Md., Dec. 3 /PRNewswire/ -...alth care system that ensures affordable, quality ...es all Americans to contact their representatives ... reform. ,, See video from ANA at: http://inr....ing for a health care system that focuses on welln...
(Date:12/3/2009)...ing moms-to-be might offer early warning of diabet... , THURSDAY, Dec. 3 (HealthDay News) -- Pregn...sugar) intolerance are at increased risk for metab...says a new study. , Gestational glucose intoler...tabolic syndrome describes a group of factors (inc...
(Date:12/3/2009)... , FREMONT, Calif., Dec. 3 /PRNewswire-USNewsw...ch (AACR) released findings today from one of the ...ast cancer in women conducted by the Northern Cal...revealed that women who never smoked cigarettes an...ver a lifetime--especially during adulthood--had a...
(Date:12/3/2009)... , Recent CBO analysis understates key fac...Dec. 3 A new actuarial ...annual medical claims in the new individual market...e years after implementation of healthcare reform ...ct (PPACA), excluding the impact of medical inflat...
Breaking Medicine News(10 mins):Health News:Americans United For Life: Senate Passes the Pro-Abortion Mikulski Amendment Under the Guise of 'Preventive Care' 2Health News:VIDEO from Medialink and the American Nurses Association (ANA): American Nurses Association Urges All Americans to Take Part in Health Care Reform Debate 2Health News:Blood Sugar Intolerance May Predict Postpartum Ills 2Health News:Northern California Cancer Center's Findings on Breast Cancer and Secondhand Smoke Released Internationally by the American Association for Cancer Research 2Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 2Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 3Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 4
... Americas Watchdog created the Mesotheli...bers & loved ones of Mesothelioma victims to g...tance at no cost to the victim, or their family me..., with the best possible free help and advice in t...
... to reduce pain in newborns undergoing painful pro...aken (venipuncture) for the newborn screening test...nna Taddio and co-authors. , In this double-blin...n administered before painful medical procedures d...
...delines on how much physical activity children nee... to be revised, conclude researchers in a study pu... in Childhood . , What,s more, less than half of ... and 99 girls from 54 different schools, all of wh...
... strategies humans use to regulate emotions can de...ses to potential rewards, a team of New York Unive...iscovered. The findings, reported in the most rece...emonstrated these strategies can alter responses t...
... June 25, 2008 marks a revolutionary day...r, the Number One Cancer Killer in this country. I...ce Day, for Lung Cancer. For the first time, in th...of Laurie Fenton, Sheila Ross and the Lung Cancer ...
...dy finds increase in non-serious side effects , ...hat contain compounds called cannabinoids from the...s side effects but are associated with an increase...ia (UBC) examined adverse events reported in 31 cl...
Other Medicine News:Health News:The Mesothelioma Victims Center Offers Victims Of Asbestos Related Cancer & Their Loved Ones The Most Comprehensive Free Service Especially For US Navy Veterans 2Health News:The Mesothelioma Victims Center Offers Victims Of Asbestos Related Cancer & Their Loved Ones The Most Comprehensive Free Service Especially For US Navy Veterans 3Health News:UK and US guidelines on kids' physical activity levels need rethinking 2Health News:NYU, Rutgers study shows how using mental strategies can alter the brain's reward circuitry 2Health News:Senators Chuck Hagel and Dianne Feinstein Make Lung Cancer Matter 2Health News:Senators Chuck Hagel and Dianne Feinstein Make Lung Cancer Matter 3Health News:Senators Chuck Hagel and Dianne Feinstein Make Lung Cancer Matter 4Health News:Drugs With Marijuana Compounds Don't Boost Adverse Events 2
Diagnosoft HARP Cardiac MRI Tagging
VISULAS YAG III Combi Complete Laser Therapy System
... Epicardia 4000 is a hospital-grade Holter Monitor...tware, Diogenes Arrhythmia and ST analysis algorit...ting hardware and software. Facilities with an Epi...running reports, customizing them to suit their ne...
Traverser™
Medicine Products: